17.655  -2.185 (-11.01%)		05-04 12:09
Open: 19.17 High: 19.17 Volume: 375,199		Pre. Close: 19.84 Low: 17.02 Market Cap: 883(M)

Short term
Mid term
Targets	6-month :	24.19	1-year :	26.86
Resists	First :	20.71	Second :	23
Pivot price	0
Supports	First :	17.02	Second :	14.16
MAs	MA(5) :	0	MA(20) :	0
	MA(100) :	0	MA(250) :	0
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	0	D(3) :	0
RSI	RSI(14): 0
52-week	High :	19.17	Low :	17.02

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SPTX ] has closed Bollinger Bands are 0% narrower than normal.

If tomorrow:	Open lower	Open higher
High:	-	-
Low:	-	-
Close:	-	-

Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines. The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts.

Sun, 03 May 2026
SPTX Price Today: Seaport Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Sat, 02 May 2026
SEAPORT THERAPEUTICS INC Statistics – NASDAQ:SPTX - TradingView

Sat, 02 May 2026
Total common shares outstanding of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView

Sat, 02 May 2026
Seaport Therapeutics, Inc. Common Stock (SPTX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Fri, 01 May 2026
SPTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Fri, 01 May 2026
Seaport, Hemab price upsized IPOs eyeing $550M in proceeds - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	-0.63
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-18.9 %
Return on Equity (ttm)	-28.1 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-78 (M)
Levered Free Cash Flow	-51 (M)

PE Ratio	-29.18
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	-0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.